Cartesian Therapeutics
RNAC
#7439
Rank
A$0.50 B
Marketcap
$18.98
Share price
3.21%
Change (1 day)
-43.67%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -A$0.12 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are A$38.91 Million. , an increase over its 2023 earnings that were of -A$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.12 Billion-67.3%
2023 -A$0.37 Billion-724%
2022 A$58.75 M-649.67%
2021 -A$10.69 Million-89.78%
2020 -A$0.11 Billion25.06%
2019 -A$83.67 Million-15.68%
2018 -A$99.23 Million-0.43%
2017 -A$99.66 Million83.41%
2016 -A$54.34 Million44.3%
2015 -A$37.66 Million